MRC Clinical Trials Unit at UCL
Menu
  • Home
  • About
    • Our Structure
      Senior Staff
      History
      Our Environmental Commitment
  • News
  • Our Research
    • Cancer
      Add-Aspirin FOCUS4 STAMPEDE RAMPART STOPCAP M1 UKCTOCS Open Studies Past Studies
      Infections
      Studies by Research Area
      Methodology
      Design Conduct Analysis Meta-analysis Software
      Other Research & Policy
      Studies in other areas Briefing Papers Data Sharing Regulatory information, Toolkits & Templates Publications
  • Studies
    • All Studies
      Studies Search
  • Patients & Public
    • About Clinical Trials
      What is a clinical trial? What is a randomised clinical trial? What is an observational study? How do we make sure a trial is safe? How is a trial designed and run? What happens at the end of a trial?
      Taking Part in a Clinical Trial
      How can you take part in a trial? What questions should you ask before participating in a trial?
      Patient & Public Involvement: Get Involved
      What is Patient & Public Involvement? About the Patient & Public Involvement Group
      Patient & Public Involvement: Resources
      Papers, Guidance & Templates Films
  • Education & Capacity Building
    • Enhancing skills of trial teams we work with across the globe
      Improving the clinical trials ecosystem
      Postgraduate Taught Courses
      Postgraduate Research Training
  • Careers
    • Our Vacancies
      Meet Our People
      Our Benefits
  • Contact

Studies in Antimicrobial Resistance

Trials on treating drug-resistant TB and other infections.

Antimicrobial resistance to drugs used to treat infections is rising. This means that for some people, standard treatments do not work, and they need to take other drugs, often with more side-effects. Our research includes trials on treating drug resistant TB and other infections.

ARREST

Adjunctive Rifampicin to Reduce Early mortality from STaphylococcus aureus bacteraemia: a multi-centre, randomised, blinded, placebo controlled trial

CDIFF

An International Prospective Observational Study to Assess the Characteristics and Outcomes of Post-transplant Patients Treated for C. Difficile Infections

NeoCHG

Does increasing concentration and frequency of applying CHG antiseptic to babies’ skin lead to a reduction in bacterial growth and does the addition of a skin softener improve the skin condition and safety of applying CHG?

  1. Home
  2. Our Research
  3. Infections
  4. Studies by Research Area
  5. Bacterial Infection

Contact Us

MRC Clinical Trials Unit at UCL
90 High Holborn
London
WC1V 6LJ

Quick links

  • News
  • Contact
  • Glossary
  • Cookies
  • Privacy

Social pages

  • twitter
  • vimeo
  • soundcloud
  • © 2021
  • Glossary
  • Sitemap
  • Accessibility
  • Cookies
  • Privacy
  • Page last updated: 04-Dec-2018 11:00